MyBlog

The Answer

>>>Setting up of a National Pharmacopoeia
In the absence of such a reference document, many Ayurvedic drugs enter the export market as nutriceuticals or dietary supplements, thereby evading the drug regulatory authorities of other countries.
The pharmacopoeia should include
1.The botanical identity of plants

As we have already mentioned in our previous blog about the various therapy packages available to a Medical tourist available in India.The packages available in India are as also available in the country of the western tourist but the advantage with India is that we in India provide the same quality of health package at an economical price.

As we have already given an introduction to the medical tourism Industry in India, from this blog onwards lets us move to the kind of packages that the Indian medical tourism industry offer to its foreign patients.Though a new destination for Medical tourism but the kind of packages offered are as par with the standard medical tourist destination across the world.

Neurotech are pioneering the implantation of encapsulated cells into the posterior section of the eye to deliver therapeutic proteins

Since the launch of pSividia’s Retisert, surgical implants have been gaining acceptance as a delivery mechanism to the posterior part of the eye.

The Issue

India offers world-class healthcare that costs substantially less than those in developed countries, using the same technology delivered by competent Specialists attaining similar success rates.

The other facilities available in India at a less price as compared to the US healthcare cost or for that matter a number of other European nations are as follows:

LYSTEDA (tranexamic acid) Tablets
Date of Approval: November 16, 2009
Company: Xanodyne Pharmaceuticals, Inc.
Treatment for: Menorrhagia

ISTODAX (romidepsin) for Injection
Date of Approval: November 5, 2009
Company: Gloucester Pharmaceuticals
Treatment for: Cutaneous T-cell Lymphoma

PENNSAID(diclofenac sodium) Topical Solution
Date of Approval: November 4, 2009

In recent years methods have been developed to access the posterior section of the eye to treat conditions such as age-related macular degeneration and diabetic retinopathy. As so little of the drug is absorbed into this part of the eye, this has involved an injection directly into the vitreous

IMMINENT CHANGES TO USP RESIDUAL SOLVENT TESTING

An important change to USP General Chapter <467> has become effective from July 1, 2008. The current
version of General Chapter <467>, called Organic Volatile Impurities, provides control limits and testing